Investment Strategy for Medical Technologies

SELECTION FOR CONSULTANTS BY THE WORLD BANK

REQUEST FOR EXPRESSIONS OF INTEREST

Electronic Submissions through World Bank Group eConsultant2
https://wbgeconsult2.worldbank.org/wbgec/index.html

ASSIGNMENT OVERVIEW

Assignment Title: 1088375 - Investment Strategy for Medical Technologies

Assignment Countries:
- (countries have not yet been selected)

ASSIGNMENT DESCRIPTION

BACKGROUND 
The International Finance Corporation (IFC), the private sector arm of the World Bank, is seeking to appoint a consultant to work with its health investment team in Washington DC to help identify opportunities for the private sector to expand in the medical technologies (medtech) sector with the aim of increasing improved health outcomes across the emerging markets.

IFC extends direct financing to private sector clients through a variety of instruments, including short and long-term loans, guarantees, and equity. Indirectly, IFC is able to finance companies through investment funds and wholesaling facilities with financial partners. IFC is also able to mobilize funds and provides advisory services to private companies and governments. Projects that IFC finances are expected to exhibit strong financial performance and meet development objectives such as increased access to quality healthcare, employment, and/or technology transfer, 

IFC currently has an investment portfolio of approximately $1.9 billion in 88 private health companies in 30 developing countries, with approximately one third of these projects located in the worlds poorest developing countries. However, very few of these investments are in the medtech sector and even fewer are focusing on developing technologies for the poor in these emerging economies.

In the medtech sector, IFC would like to assess its ability to support companies that have, or are developing products and solutions that have an outcome-based approach, ie: that effectively target critical communicable and non-communicable diseases. IFC can support medtech companies involved in technology transfer from developed countries to developing countries (via localized manufacturing, research support, or distribution networks, for example) or indigenous medtech companies that are based in emerging markets. IFCs goal in health is to increase access to quality and affordable healthcare, so the aim of this study is to find solutions that provide new, better or improved products to patients in the developing world. Some of these solutions should be inclusive business companies with the potential to expand health access to those at the base of the pyramid (defined as those living at less than $8/ppp a day or whom lack access to basic goods, services, and livelihood opportunities). Communicable diseases continue to be an issue in the poorest countries in the world. However, non-communicable diseases such as cardiovascular, cancer and diabetes are taking an increasing human and economic toll in many emerging markets, so particular attention should be given to how IFC can help improve identification, prevention, and treatment of these diseases in those markets.

SCOPE OF WORK:

The study shall describe the medical technology sector, achieving the following:

1.Identification and mapping of the medical technology universe in the following sub-sectors: 

Medical (including diagnostic) equipment;
Medical products (e.g. orthopedic, implantable, dental); and
Select consumables

with the goal of setting the context for the areas of focus to be identified in the study. This mapping should identify demand and supply dynamics in the space and should further highlight areas which present growth opportunities

2. Sub-Sector Analysis
a) Identify activities (e.g., sales and distribution, manufacturing and scale-up, maintenance, training, around each of the sub-sectors noted above; (b) identify the financing and investment requirements for each of these activities; and (c) identify the qualitative development impact of these activities and relevant measures. 

3. Identification and Prioritization of Opportunities
Identify priority sub-sectors, countries and eventually companies in the space that present specific investment opportunities for IFC. Companies can be in emerging markets (i.e. where developmental results would be greatest or there is an indigenous medtech industry) and developed countries. For the developed countries, the consultant shall review activities in North America, Europe, Japan, and Israel seeking to identify medical technologies of wide applicability to the emerging markets.

QUALIFICATIONS:
Firm should be able to demonstrate experience in medical technology sector, both in emerging and developed countries (e.g. Japan/EU/US/Israel).

FIRM MUST BE REGISTERED IN ISRAEL TO BE ELIGIBLE FOR THIS ASSIGNMENT. 

PLEASE LIMIT EOI to 10 PAGES. 

FUNDING SOURCE

The World Bank intends to finance the assignment / services described below under the following trust fund(s):
- BANK BUDGET
- IFC/Israel Technical Assistance Trust Fund

ELIGIBILITY

Eligibility restrictions apply:
FIRM MUST BE REGISTERED IN ISRAEL TO BE ELIGIBLE FOR THIS ASSIGNMENT.

INDIVIDUAL / FIRM PROFILE
The consultant will be a firm. 

SUBMISSION REQUIREMENTS
The World Bank now invites eligible consultants to indicate their interest in providing the services. Interested consultants must provide information indicating that they are qualified to perform the services (brochures, description of similar assignments, experience in similar conditions, availability of appropriate skills among staff, etc. for firms; CV and cover letter for individuals). Please note that the total size of all attachments should be less than 5MB. Consultants may associate to enhance their qualifications.

Interested consultants are hereby invited to submit expressions of interest.

Expressions of Interest should be submitted, in English, electronically through World Bank Group eConsultant2 (https://wbgeconsult2.worldbank.org/wbgec/index.html)

NOTES
Following this invitation for Expression of Interest, a shortlist of qualified firms will be formally invited to submit proposals. Shortlisting and selection will be subject to the availability of funding.

Qualification Criteria

• 1. Firms must be registered in Israel to be eligible for this assignment. *
• 2. Firm demonstrates experience in the medical technology sector (medical equipment including diagnostics; medical products including implants, orthopedic, and dental; medical consumables), including direct experience working with/for companies in this sector. *
• 3. Networks in and sector experience in key developed (US/EU/Japan/Israel) and developing markets relevant for this study *
• 4. Proposed project staff have direct experience in medical technology sector, as demonstrated by their CV and description of project experience *
• 5. Submission must be 10 pages or less (excluding CVs) *

* - Mandatory